Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
Rilparencel by Prokidney for Unspecified Genito Urinary Disorders: Likelihood of Approval
Rilparencel is under clinical development by Prokidney and currently in Phase I for Unspecified Genito Urinary Disorders. According to GlobalData,...
Rilparencel by Prokidney for Diabetic Nephropathy: Likelihood of Approval
Rilparencel is under clinical development by Prokidney and currently in Phase III for Diabetic Nephropathy. According to GlobalData, Phase III...
Rilparencel by Prokidney for Chronic Kidney Disease (Chronic Renal Failure): Likelihood of Approval
Rilparencel is under clinical development by Prokidney and currently in Phase III for Chronic Kidney Disease (Chronic Renal Failure). According...
Rilparencel by Prokidney for Type 2 Diabetes: Likelihood of Approval
Rilparencel is under clinical development by Prokidney and currently in Phase III for Type 2 Diabetes. According to GlobalData, Phase...
Rilparencel by Prokidney for Type 1 Diabetes (Juvenile Diabetes): Likelihood of Approval
Rilparencel is under clinical development by Prokidney and currently in Phase II for Type 1 Diabetes (Juvenile Diabetes). According to...